FR2133979A1 - - Google Patents

Info

Publication number
FR2133979A1
FR2133979A1 FR7214052A FR7214052A FR2133979A1 FR 2133979 A1 FR2133979 A1 FR 2133979A1 FR 7214052 A FR7214052 A FR 7214052A FR 7214052 A FR7214052 A FR 7214052A FR 2133979 A1 FR2133979 A1 FR 2133979A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7214052A
Other languages
French (fr)
Other versions
FR2133979B1 (hr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck et Cie
Merck and Co Inc
Original Assignee
Merck et Cie
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck et Cie, Merck and Co Inc filed Critical Merck et Cie
Publication of FR2133979A1 publication Critical patent/FR2133979A1/fr
Application granted granted Critical
Publication of FR2133979B1 publication Critical patent/FR2133979B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7214052A 1971-04-21 1972-04-20 Expired FR2133979B1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13618671A 1971-04-21 1971-04-21
US13818671A 1971-04-21 1971-04-21

Publications (2)

Publication Number Publication Date
FR2133979A1 true FR2133979A1 (hr) 1972-12-01
FR2133979B1 FR2133979B1 (hr) 1975-10-31

Family

ID=26834087

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7214052A Expired FR2133979B1 (hr) 1971-04-21 1972-04-20

Country Status (4)

Country Link
DE (1) DE2219408A1 (hr)
FR (1) FR2133979B1 (hr)
GB (1) GB1356763A (hr)
NL (1) NL7204972A (hr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011258217B2 (en) * 2010-05-26 2016-12-15 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
CN111944340A (zh) * 2020-08-21 2020-11-17 何瑞坚 一种耐盐雾防锈涂料

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667300B2 (en) 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
ES2605792T3 (es) 2004-05-13 2017-03-16 Icos Corporation Quinazolinona usada como inhibidor de la fosfatidilinositol 3-quinasa delta humana
WO2010057048A1 (en) 2008-11-13 2010-05-20 Calistoga Pharmaceuticals Inc. Therapies for hematologic malignancies
US9492449B2 (en) 2008-11-13 2016-11-15 Gilead Calistoga Llc Therapies for hematologic malignancies
CN102439012A (zh) 2009-03-24 2012-05-02 吉里德卡利斯托加公司 2-嘌呤基-3-甲苯基-喹唑啉酮衍生物的阻转异构体和使用方法
KR20120005523A (ko) 2009-04-20 2012-01-16 길리아드 칼리스토가 엘엘씨 고형 종양의 치료 방법
AU2010276160A1 (en) 2009-07-21 2012-02-09 Gilead Calistoga Llc Treatment of liver disorders with PI3K inhibitors
EP3210984B1 (en) 2011-01-11 2019-06-19 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
ES2848273T3 (es) 2012-03-05 2021-08-06 Gilead Calistoga Llc Formas polimórficas de (S)-2-(1-(9H-purin-6-ilamino)propilo)-5-fluoro-3-fenilquinazolina-4(3H)-ona
SG11201604825VA (en) 2013-12-20 2016-07-28 Gilead Calistoga Llc Process methods for phosphatidylinositol 3-kinase inhibitors
AU2014364414A1 (en) 2013-12-20 2016-06-30 Gilead Calistoga Llc Polymorphic forms of a hydrochloride salt of (S) -2-(1-(9H-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3H) -one
KR20170012560A (ko) 2014-06-13 2017-02-02 길리애드 사이언시즈, 인코포레이티드 포스파티딜이노시톨 3-키나제 억제제

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011258217B2 (en) * 2010-05-26 2016-12-15 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
EP2576540B1 (en) * 2010-05-26 2019-09-04 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
CN111944340A (zh) * 2020-08-21 2020-11-17 何瑞坚 一种耐盐雾防锈涂料

Also Published As

Publication number Publication date
GB1356763A (en) 1974-06-12
FR2133979B1 (hr) 1975-10-31
DE2219408A1 (de) 1972-10-26
NL7204972A (hr) 1972-10-24

Similar Documents

Publication Publication Date Title
FR2133979B1 (hr)
AU2658571A (hr)
AU3005371A (hr)
AU2564071A (hr)
AU2684071A (hr)
AU2742671A (hr)
AU2894671A (hr)
AU2941471A (hr)
AU2952271A (hr)
AU2836771A (hr)
AU2726271A (hr)
AU2577671A (hr)
AU2588771A (hr)
AU2654071A (hr)
AU2684171A (hr)
AU2669471A (hr)
AU2399971A (hr)
AU2706571A (hr)
AU3025871A (hr)
AU3038671A (hr)
AU2963771A (hr)
AU2724971A (hr)
AU2755871A (hr)
AU2940971A (hr)
AU2938071A (hr)

Legal Events

Date Code Title Description
ST Notification of lapse